Resveratrol Suppresses Microcirculatory Disturbance in a Rat Model of Severe Acute Pancreatitis

Cell Biochemistry and Biophysics

Volumn 67, Issue 3, 2013, Pages 1059-1065

  Sha, Huanchen ^a   Ma, Qingyong ^a   Jha, Rajiv Kumar ^a   Wu, Zheng ^a   Qingyuan, Zhang ^a   Wang, Zheng ^a   Ma, Zhenhua ^a   Luo, Xianhua ^b   Liu, Cui ^b  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Angiotensin II; Microcirculatory disturbance; Plasma renin activity; Resveratrol; Severe acute pancreatitis

Indexed keywords

ANGIOTENSIN II; ENDOTHELIN; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; RENIN; RESVERATROL; STILBENE DERIVATIVE; TAUROCHOLIC ACID;

ACUTE DISEASE; ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; METABOLISM; MICROCIRCULATION; PANCREAS; PANCREATITIS; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ACUTE DISEASE; ANGIOTENSIN II; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; ENDOTHELINS; MICROCIRCULATION; NITRIC OXIDE; PANCREAS; PANCREATITIS; RATS; RATS, SPRAGUE-DAWLEY; RENIN; STILBENES; TAUROCHOLIC ACID;

EID: 84888383814     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9604-x     Document Type: Article

References (34)

1. Sand, J., & Nordback, I. (2009). Acute pancreatitis: Risk of recurrence and late consequences of the disease. Nature Reviews Gastroenterology & Hepatology, 6, 470-477.
2. Whitcomb, D. C. (2006). Clinical practice. Acute pancreatitis. The New England Journal of Medicine, 2006(354), 2142-2150.
3. Petrov, M. S., Shanbhag, S., Chakraborty, M., Phillips, A. R., & Windsor, J. A. (2010). Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology, 139, 813-820.
4. Lu, F., Huang, H., Wang, F., & Chen, Y. (2011). Intestinal capillary endothelial barrier changes in severe acute pancreatitis. Hepato-Gastroenterology, 58, 1009-1017.
5. Du, X., Cao, Y., Xue, P., Lin, Z., Zeng, Z., & Xia, Q. (2011). Protective effect of intermedin on myocardial cell in a rat model of severe acute pancreatitis. Cellular & Molecular Biology Letters, 16, 462-476.
6. Bhatia, M., Wong, F. L., Cao, Y., Lau, H. Y., Huang, J., Puneet, P., et al. (2005). Pathophysiology of acute pancreatitis. Pancreatology, 5, 132-144.
7. Ito, Y., Lugea, A., Pandol, S. J., & McCuskey, R. S. (2007). Substance P mediates cerulein-induced pancreatic microcirculatory dysfunction in mice. Pancreas, 34, 138-143.
8. Leach, S. D., Gorelick, F. S., & Modlin, I. M. (1992). New perspectives on acute pancreatitis. Scandinavian Journal of Gastroenterology Supplement, 192, 29-38.
9. Takaoka, M. (1939). Resveratrol, a new phenolic compound, from Veratrum Grandiflorum. Journal of chemical society of Japan, 60, 1090-1100.
10. Cai, Z., Knorr, D., & Smetanska, I. (2012). Enhanced anthocyanins and resveratrol production in Vitis vinifera cell suspension culture by indanoyl-isoleucine, N-linolenoyl-l-glutamine and insect saliva. Enzyme and Microbial Technology, 50, 29-34.
11. Piotrowska, H., Kucinska, M., & Murias, M. (2012). Biological activity of piceatannol: Leaving the shadow of resveratrol. Mutation Research, 750(1), 60-82.
12. Baolin, L., Inami, Y., Tanaka, H., Inagaki, N., Iinuma, M., & Nagai, H. (2004). Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro. Planta Medica, 70, 305-309.
13. Bhat, K. P. L., Kosmeder, J. W., & Pezzuto, J. M. (2001). Biological effects of resveratrol. Antioxidants & Redox Signaling, 3, 1041-1064.
14. Ma, Z. H., & Ma, Q. Y. (2005). Resveratrol: A medical drug for acute pancreatitis. World Journal of Gastroenterology, 11, 3171-3174.
15. Olas, B., & Wachowicz, B. (2001). Biological activity of resveratrol. Poste{ogonek}py Higieny i Medycyny Doświadczalnej, 55, 71-79.
16. Zagler, B., Zelger, A., Salvatore, C., Pechlaner, C., De, G. F., & Wiedermann, C. J. (2005). Dietary poisoning with Veratrum album: A report of two cases. Wiener Klinische Wochenschrift, 117, 106-108.
17. Karalis, F., Soubasi, V., Georgiou, T., Nakas, C. T., Simeonidou, C., Guiba-Tziampiri, O., et al. (2011). Resveratrol ameliorates hypoxia/ischemia-induced behavioral deficits and brain injury in the neonatal rat brain. Brain Research, 1425, 98-110.
18. Triester, S. L., & Kowdley, K. V. (2002). Prognostic factors in acute pancreatitis. Journal of Clinical Gastroenterology, 34, 167-176.
19. Di Fabio, F., Abu, H. M., & Johnson, C. D. (2011). Acute pancreatitis: Mild, severe or potentially fatal. Pancreatology, 11, 373-375.
20. Zhang, X. P., Li, Z. J., & Zhang, J. (2009). Inflammatory mediators and microcirculatory disturbance in acute pancreatitis. Hepatobiliary & Pancreatic Diseases International, 8, 351-357.
21. Chen, P., Huang, L., Sun, Y., & Yuan, Y. (2011). Upregulation of PIAS1 protects against sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury. Cytokine, 54, 305-314.
22. Ji, R. L., Xia, S. H., Di, Y., & Xu, W. (2011). Mechanism and dose-effect of Ginkgolide B on severe acute pancreatitis of rats. World Journal of Gastroenterology, 17, 2241-2247.
23. Jha, R. K., Ma, Q., Sha, H., & Palikhe, M. (2009). Protective effect of resveratrol in severe acute pancreatitis-induced brain injury. Pancreas, 38, 947-953.
24. Li, Z. D., Ma, Q. Y., & Luo, Y. H. (2009). Effect of resveratrol-induced FasL up-regulation on the apoptosis of pancreatic acinar cells in rats with severe acute pancreatitis. Nan Fang Yi Ke Da Xue Xue Bao, 29, 454-457.
25. Sha, H., Ma, Q., Jha, R. K., & Wang, Z. (2009). Resveratrol ameliorates lung injury via inhibition of apoptosis in rats with severe acute pancreatitis. Experimental Lung Research, 35, 344-358.
26. Oruc, N., Ozutemiz, O., Nart, D., Yuce, G., Celik, H. A., & Ilter, T. (2010). Inhibition of renin-angiotensin system in experimental acute pancreatitis in rats: A new therapeutic target? Experimental and Toxicologic Pathology, 62, 353-360.
27. Ip, S. P., Tsang, S. W., Wong, T. P., Che, C. T., & Leung, P. S. (2003). Saralasin, a nonspecific angiotensin II receptor antagonist, attenuates oxidative stress and tissue injury in cerulein-induced acute pancreatitis. Pancreas, 26, 224-229.
28. Tsang, S. W., Cheng, C. H., & Leung, P. S. (2004). The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis. Regulatory Peptides, 119, 213-219.
29. Zhang, X. P., Zhang, J., Ma, M. L., Cai, Y., Xu, R. J., Xie, Q., et al. (2010). Pathological changes at early stage of multiple organ injury in a rat model of severe acute pancreatitis. Hepatobiliary & Pancreatic Diseases International, 9, 83-87.
30. Rahman, S. H., Ammori, B. J., Larvin, M., & McMahon, M. J. (2003). Increased nitric oxide excretion in patients with severe acute pancreatitis: Evidence of an endotoxin mediated inflammatory response? Gut, 52, 270-274.
31. Jaworek, J., Jachimczak, B., Tomaszewska, R., Konturek, P. C., Pawlik, W. W., Sendur, R., et al. (2000). Protective action of lipopolysaccharides in rat caerulein-induced pancreatitis: Role of nitric oxide. Digestion, 62, 1-13.
32. Al-Mufti, R. A., Williamson, R. C., & Mathie, R. T. (1998). Increased nitric oxide activity in a rat model of acute pancreatitis. Gut, 43, 564-570.
33. Wang, Z., Ma, O. Y., Ren, L., Li, Z. D., & Li, L. (2006). The study in resveratrol function to acute lung injury sourced from severe acute pancreatitis. Sichuan Da Xue Xue Bao Yi Xue Ban, 37, 904-907.
34. Satoh, A., Shimosegawa, T., Kimura, K., Moriizumi, S., Masamune, A., Koizumi, M., et al. (1998). Nitric oxide is overproduced by peritoneal macrophages in rat taurocholate pancreatitis: The mechanism of inducible nitric oxide synthase expression. Pancreas, 17, 402-411.